Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
about
Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.MicroRNA-195: a review of its role in cancers
P2860
Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Eribulin upregulates miR-195 e ...... breast cancer cell MDA-MB-231.
@en
type
label
Eribulin upregulates miR-195 e ...... breast cancer cell MDA-MB-231.
@en
prefLabel
Eribulin upregulates miR-195 e ...... breast cancer cell MDA-MB-231.
@en
P2093
P2860
P1433
P1476
Eribulin upregulates miR-195 e ...... breast cancer cell MDA-MB-231.
@en
P2093
Akiko Sasaki
Hideto Oyamada
Hiromichi Tsuchiya
Kanji Furuya
Katsuji Oguchi
Mayumi Tsuji
Yuko Tsunoda
Yuko Udaka
P2860
P2888
P356
10.1007/S13577-015-0126-2
P577
2015-11-16T00:00:00Z
P6179
1051819347